Yi-Fang Liu

Dec 3, 2024 | mdpi.com | Yi-Fang Liu |Yi-Chen Wu |Yu Yang |Hui-Chen Lo

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

May 15, 2023 | onlinelibrary.wiley.com | Ming-Zi Zhang |Yi-Fang Liu |Zhi-Jin Li |Yun-Zhu Li

4 DISCUSSION Although a keloid is regarded as a benign tumor, its continuous growth characteristics and accompanying symptoms can seriously affect patients' life quality.9-11 The imbalance state between cell proliferation and apoptosis may lead to keloid continuous growth characteristics.7 In this case, effective drugs for keloid treatment may not only promote the cell apoptosis level but also inhibit the cell proliferation level.

Mar 21, 2023 | mdpi.com | Su-Yu Huang |Yi-Wen Chen |Yi-Fang Liu |Wan-Jing Chen

Open AccessArticlebyWan-Jing Chen 1,†, Su-Yu Huang 2,†, Yi-Wen Chen 2, Yi-Fang Liu 1,2 and Rwei-Fen S. Huang 1,2,* 1Program in Nutrition and Food Science, Fu Jen Catholic University, New Taipei City 242, Taiwan2Department of Nutritional Science, Fu Jen Catholic University, New Taipei City 242, Taiwan*Author to whom correspondence should be addressed. †These authors contributed equally to this work.